GM1 gangliosidosis

Views & Analysis

Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner.

News

Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.